These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 23697493)
1. The global impact of Indian generics on access to health. Ravinetto RM; Dorlo TP; Caudron JM; Prashanth NS Indian J Med Ethics; 2013; 10(2):118-20. PubMed ID: 23697493 [No Abstract] [Full Text] [Related]
2. Is India ready to lead the battle for fair access to medicines? Lancet Oncology Lancet Oncol; 2013 May; 14(6):437. PubMed ID: 23639313 [No Abstract] [Full Text] [Related]
3. US trade rep is pressing Indian government to forbid production of generic cancer drug, consortium says. Cohen D BMJ; 2014 Nov; 349():g6593. PubMed ID: 25370846 [No Abstract] [Full Text] [Related]
4. Compulsory licensing in Canada and Thailand: comparing regimes to ensure legitimate use of the WTO rules. Lybecker KM; Fowler E J Law Med Ethics; 2009; 37(2):222-39. PubMed ID: 19493068 [TBL] [Abstract][Full Text] [Related]
5. Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects. Bird RC J Law Med Ethics; 2009; 37(2):209-21. PubMed ID: 19493067 [TBL] [Abstract][Full Text] [Related]
6. Prescription drug prices in the US. Med Lett Drugs Ther; 2017 May; 59(1521):81-83. PubMed ID: 28520697 [No Abstract] [Full Text] [Related]
7. Patent dispute: Delhi High Court gives a boost to access to affordable medicines. Menghaney L Indian J Med Ethics; 2010; 7(2):97-100. PubMed ID: 20432882 [TBL] [Abstract][Full Text] [Related]
8. Commentary: innovation policy for a new era. Kapczynski A J Law Med Ethics; 2009; 37(2):264-8. PubMed ID: 19493071 [TBL] [Abstract][Full Text] [Related]
9. Access to drugs: the case of Abbott in Thailand. Cawthorne P; Ford N; Wilson D; Kijtiwatchakul K; Purahong V; Tianudom N; Nacapew S Lancet Infect Dis; 2007 Jun; 7(6):373-4. PubMed ID: 17521589 [No Abstract] [Full Text] [Related]
10. Taking TRIPS to India--Novartis, patent law, and access to medicines. Mueller JM N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473 [No Abstract] [Full Text] [Related]
11. Making tenofovir accessible in the brazilian public health system: patent conflicts and generic production. Veras J Dev World Bioeth; 2014 Aug; 14(2):92-100. PubMed ID: 24889312 [TBL] [Abstract][Full Text] [Related]
12. Access to AIDS medicine: ethical considerations. Swartz O Indian J Med Ethics; 2004; 1(3):75-6. PubMed ID: 16370076 [No Abstract] [Full Text] [Related]
13. A trade agreement's impact on access to generic drugs. Shaffer ER; Brenner JE Health Aff (Millwood); 2009; 28(5):w957-68. PubMed ID: 19706626 [TBL] [Abstract][Full Text] [Related]
14. Patents and human rights: a heterodox analysis. Gold ER J Law Med Ethics; 2013; 41(1):185-98. PubMed ID: 23581665 [TBL] [Abstract][Full Text] [Related]
15. The cost of prescription drugs: rising concerns over equity, fairness and access to essential care. Work DR; Domino ME N C Med J; 2003; 64(6):270-4. PubMed ID: 14983614 [No Abstract] [Full Text] [Related]
16. A tragically naive Canadian law for tragically neglected global health. Attaran A CMAJ; 2007 Jun; 176(12):1726-7. PubMed ID: 17449707 [No Abstract] [Full Text] [Related]
18. [Supply shortages of drugs - a global problem]. Bruhn C Dtsch Med Wochenschr; 2012 Aug; 137(34-35):1676-7. PubMed ID: 23066532 [No Abstract] [Full Text] [Related]
20. India: New patent law may restrict access to HIV/AIDS treatments. Cruess G HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]